Related Experiment Video
Updated: Jul 11, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Bone mass in elderly patients with Parkinson's disease
B Lorefält1, G Toss, A-K Granérus
1Department of Medicine and Care, Linköping University, Sweden. birgitta.lorefalt@imv.liu.se
Acta Neurologica Scandinavica
|September 11, 2007
Summary
Low body weight and reduced physical activity are key risk factors for decreased bone mineral density (BMD) in Parkinson's disease (PD) patients. Rigidity may offer a protective effect against bone loss in this population.
Area of Science:
- Neurology
- Bone Metabolism
- Geriatrics
Background:
- Parkinson's disease (PD) is associated with an increased risk of osteoporosis and fractures.
- Understanding risk factors for low bone mineral density (BMD) in PD is crucial for preventative strategies.
Purpose of the Study:
- To identify risk factors associated with low bone mineral density (BMD) in individuals diagnosed with Parkinson's disease (PD).
Main Methods:
- A cohort study involving 26 PD patients and 26 age- and sex-matched healthy controls, assessed over a one-year period.
- Evaluated PD symptoms, body weight, body fat mass, BMD, physical activity levels, smoking status, and serum laboratory markers.
- Utilized BMD measurements and Z-scores at various skeletal sites.
Main Results:
- PD patients exhibited lower BMD compared to controls, with a significant decrease observed over the study year.
- Low body weight was identified as a predictor of lower BMD in PD patients.
- Trochanteric BMD Z-score correlated positively with physical activity and negatively with recumbent rest duration. Total body BMD Z-score correlated positively with rigidity.
- Serum 25-hydroxy-vitamin D levels were slightly lower in the PD group.
Conclusions:
- Low body weight and reduced physical activity are significant risk factors for low BMD in Parkinson's disease.
- Increased rigidity, a common PD symptom, may have a protective effect on bone mineral density.
- These findings highlight the importance of monitoring BMD and addressing modifiable risk factors in PD management.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...